Definition of Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH conjugate vaccine - National Cancer Institute Drug Dictionary

Page Options

	Quick Links


	Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports Science Serving People Learn more about NCI Español Información en español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

Quit Smoking Today

	NCI Highlights


	Report to Nation Finds Declines in Cancer Incidence, Death Rates High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E The Nation's Investment in Cancer Research FY 2009 Past Highlights

Search for

Starts with

Contains

All

Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH conjugate vaccine
A heptavalent vaccine consisting of the tumor-associated carbohydrate antigens globohexaosylceramide (globo-H), GM2, Lewis-y, MUC1-32(aa), sTn(c), TF(c), and Tn(c) conjugated with keyhole limpet hemocyanin (KLH), an immunomodulator. This vaccine may induce the production of IgG and IgM antibodies and an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumors expressing these antigens. Check for or using this agent. ()

Abbreviation:		GLO-GM2-LE-MUC1-sTN-TF-TN-KLH

Previous:	ginger extract, Girostan, Gleevec, Gliadel wafer, glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine
Next:	glucarpidase, Glucophage, glutamine, glutathione disulfide NOV-002, glycine